Global Infectious Respiratory Disease Diagnostics Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Infectious respiratory disease is caused by germs including bacteria, viruses, or further pathogenic microbes, which are generally spread via saliva and mucus when a person coughs, talks, sneezes, or laughs. Accordingly, infectious respiratory disease diagnostics help in the detection of germs in a patient with a compatible clinical illness. The increasing incidences of infectious respiratory diseases, rising number of initiatives by the government and non-profit organizations to provide advanced healthcare services, and rising penetration of molecular techniques are upsurging the market demand across the globe.

According to the World Health Organization (WHO), respiratory disease infection is considered the third major cause of death with approximately 3 million death per year (6% of global deaths), in which nearly 90% of COPD fatalities occur in those 70-year-old people from the low-and middle-income countries. Also, there are around 262 million patients were estimated to suffer from asthma, which commonly affects children. Therefore, the high prevalence of infectious respiratory diseases acts as a catalyzing factor for the market demand. Moreover, the increasing technological advancement in respiratory disease testing and growing R&D investments in respiratory disease testing are presenting lucrative prospects for market growth in the forthcoming years. However, high prices of diagnostic products and the presence of stringent regulatory frameworks are hindering market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Infectious Respiratory Disease Diagnostics Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the space in terms of revenue, owing to the availability of well-established healthcare facilities and increasing healthcare expenditure. Whereas, the Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as growing incidences of target diseases, increasing geriatric population, and rising emphasis on testing rates.

Major market players included in this report are:

Abbott

Thermo Fisher Scientific, Inc.

Koninklijke Philips N.V.

F. Hoffmann-La Roche Ltd.

bioMerieux SA

Bio-Rad Laboratories, Inc.

Quidel Corporation

Siemens Healthcare GmbH

Danaher

Qiagen

Recent Developments in the Market:

In September 2020, F. Hoffmann-La Roche Ltd. announced the introduction of Elecsys Anti-SARS-CoV-2 S antibody test in markets accepting CE marking. The company filed for EUA to launch its product across the United States and focus on the launch of multiplex diagnostic tests for COVID-19, RSV, and influenza.
Global Infectious Respiratory Disease Diagnostics Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered Product Type, Sample Type, Technology, Application, Region

Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

Instruments

Consumables

Services

By Sample Type:

Saliva

Nasopharyngeal Swabs (NPS)

Anterior Nasal Region

Blood

Others

By Technology:

Immunoassay

Molecular Diagnostics

Microbiology

Other Technologies

By Application:

COVID-19

Influenza

Respiratory Syncytial Virus (RSV)

Tuberculosis

Streptococcus Testing

Other Respiratory Disease Testing

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World